United States· US:72789-251_40ad376a-ff01-ce39-e063-6294a90a7174

Cephalexin

A cefalexin product containing cephalexin, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 14 of our 19 countries.

ATC J01DB01Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCephalexinATCJ01DB01REGISTER NO.US:72789-251_40ad376a…PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Cefalexin is registered in 14 of 19 countries.

Countries holding a registration under ATC J01DB01 (cefalexin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Cefalexin · ATC J01DB01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefalexin costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $0.72 in United States to $1.28 in Spain — a ×1.8 gap.

  • United States: $0.72 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Cefalexin · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • ES Spain$1.28
  • US United States$0.72 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Cephalexin
Manufacturer
PD-Rx Pharmaceuticals, Inc.
Country
United States (US)
ATC code
J01DB01
ATC class
Cefalexin
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    7278925182
    500 CAPSULE in 1 BOTTLE, PLASTIC (72789-251-82)

Regulatory notes

UNII (FDA substance ID)
OBN7UDS42Y
CEPHALEXIN
RxCUI 215948
Orange Book
A090836
ABABAB
DailyMed SPL labels
1 version tracked

Interactions

223 interactions on record for cefalexin.

Graded by severity as the source publishes them — 13 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefalexin · interactions on record

223 records

  • 13 moderate
  • 210 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • BalsalazideA07EC04moderate
  • MetforminA10BA02moderate
  • DicoumarolB01AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefalexin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefalexin products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Cephalobene, Keflex
  • Belgium · Keforal
  • Bulgaria · Оспексин
  • Cyprus · Felexin, Keflex
  • Germany · Cefalexin Reiwa Healthcare, Cephalex-Ct
  • Denmark · Keflex
  • Spain · Cefalexina Normon, Cefalexina Reiwa Healthcare
  • Finland · Kefalex, Kefexin
  • France · Keforal, Kéforal
  • United Kingdom (Northern Ireland) · Cefalexin, Cefalexin Ascend Laboratories (Uk)
  • Croatia · Cefaleksin Belupo, Cefalexin Alkaloid
  • Hungary · Cefalexin Reiwa Healthcare, Pyassan 250 Mg Kemény Kapszula
  • Ireland · Keflex
  • Italy · Ceporex, Keforal
  • Luxembourg · Keforal
  • Malta · Keflex
  • Netherlands · Keforal
  • Norway · Keflex
  • Poland · Cefaleksyna Tzf
  • Romania · Cefalexină Arena, Cefalexina Atb
  • Slovakia · Ospexin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9a5028a-6d84-436a-892c-f454ba0d293d
GET /v1/drugs/d9a5028a-6d84-436a-892c-f454ba0d293d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "OBN7UDS42Y",
    "rxcui": "215948",
    "inchikey": "AVGYWQBCYZHHPN-CYJZLJNKSA-N",
    "display_name": "CEPHALEXIN",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 2
  },
  "spl_meta": {
    "4ecf9314-76e2-c270-e063-6294a90ad8db": {
      "match": "brand_token",
      "title": "CEPHALEXIN CAPSULE [NORTHWIND HEALTH COMPANY, LLC]",
      "spl_version": "2",
      "published_date": "2026-05-25"
    }
  },
  "productid": "72789-251_40ad376a-ff01-ce39-e063-6294a90a7174",
  "productndc": "72789-251",
  "dosage_form": "CAPSULE",
  "orange_book": {
    "appl_no": "090836",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 250MG BASE",
        "product_no": "001",
        "approval_date": "Dec 20, 2010"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 500MG BASE",
        "product_no": "002",
        "approval_date": "Dec 20, 2010"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": null,
        "strength": "EQ 333MG BASE",
        "product_no": "003",
        "approval_date": "Mar 29, 2013"
      },
      {
        "rs": true,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 750MG BASE",
        "product_no": "004",
        "approval_date": "Mar 29, 2013"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "CEPHALEXIN",
  "proprietary_name": "Cephalexin",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA090836",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Cephalexin",
  "start_marketing_date": "20110119",
  "active_numerator_strength": "500"
}

See everything about cefalexin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.